Thursday, May 19, 2022 12:59:55 PM
Good question. I wish I knew, but of course, no one knows what the SP will be when the official TLD is released and the journal article is published, nor how far the SP will fall when the next hit piece arrives. But I have a suspicion that the recent academic presentation will not have aided AF and his criminal gang's next move. There are too many unknown variables to make a convincing prediction. For example, a whale could come in at some point and start propping up the SP like Neil Woodford did way back when. But your scenario of having to live with SPs under $2 until est. approval 1Q 2023 doesn't seem far-fetched either, and it just may be how things play out. I can live with that, too, as long as we continue to steadily march towards approval. This possibility is why I am simply focusing on BLA submissions and approval by the first RA. Slinging mud in the interim is easy, but I honestly don't see anyone on this board doing a better job. If anything, NWBO would already be out of business if some of these posters were at the helm. Personally, I may sell a few shares here and there to keep my own lights on, but I'm basically holding until a few years down the road, whether it be via partnership, BO, or going it alone. Each of us deals with this stressful situation in our own way. Some need to constantly criticize management and vent here on this board, and I get that. Personally, I pray a lot for Linda Powers and invite everyone else here to do the same if so inclined. This is a spiritual battle just as much as it is anything else in my view, and she's up against a formidable evil force, pure and simple. However, God is way more powerful than those fools. I am sure many of the cancer patients, their families, and their oncologists are hoping and praying for Linda and DCVax-L's approval ASAP. Anyway, that's how I deal with all this stuff. For me it's the only way to make a contribution, be at peace, and be confident that our prayers will be answered. God's will be done. Best wishes.
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
